Published in Blood Weekly, July 29th, 2004
"Factor Xa (fXa) is a serine protease involved in the coagulation cascade, which has received great interest as a potential target for the development of new antithrombotic drugs," scientists in Japan explained.
H. Koshio and colleagues working with Yamanouchi Pharmaceutical Co. Ltd. presented a "series of fXa inhibitors in which the 1,4-diazepane moiety was designed to interact with the S4 aryl-binding domain of the fXa active site."
"Compound 13 (YM-96765) showed potent fXa inhibitory activity (IC50 =6.8 nM) and...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.